Finally, the presence of a potent suppressive CD4+Foxp3− T cell population was revealed within the colorectal tumor regulatory landscape by comparison of healthy colon, colorectal tumor samples, and matched blood from CRC patients [44]. This evidence concerns the gene CD4 and colorectal neoplasm.